Geode Capital Management
MENS

Geode Capital Management’s Jyong Biotech MENS Stock Holding History

Geode Capital Management’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143K Buy
68,882
+4,650
+7% +$9.87K ﹤0.01% 4019
2026
Q1 		$138K Sell
64,232
-150
-0.2% -$367 ﹤0.01% 4040
2025
Q4 		$254K Buy
64,382
+10,538
+20% +$372K ﹤0.01% 3831
2025
Q3 		$2.12M Buy
+53,844
New +$1.94M ﹤0.01% 3164

Other funds holding MENS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management's MENS Position: Q2 2026 in Review

Geode Capital Management increased its Jyong Biotech (MENS) stake by 7.2% in Q2 2026, buying an estimated $9.87K and bringing the position to 68,882 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #4019.

Geode Capital Management first reported a position in MENS in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.12M in Q3 2025. 19 funds tracked by Wall St. Rank hold MENS as of Q2 2026.

  • Geode Capital Management held 68,882 shares of Jyong Biotech worth $143K as of Q2 2026.
  • Geode Capital Management bought 4,650 Jyong Biotech shares in Q2 2026, an estimated $9.87K.
  • Jyong Biotech made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4019 holding.
  • Geode Capital Management first reported a position in Jyong Biotech in Q3 2025 and has held it in 4 quarters since.
  • Geode Capital Management's Jyong Biotech position peaked at $2.12M in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Jyong Biotech as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.